TCT-635 Cost Effectiveness Of Everolimus-Eluting Stents Compared To First Generation Drug-Eluting Stents In Contemporary Clinical Practice

Everolimus-eluting stents (EES) reduce adverse clinical outcomes compared to first generation drug-eluting stents (DES) and cost less. Whether EES demonstrate cost-effectiveness compared to DES within high risk patient subgroups is uncertain. Percutaneous coronary intervention with EES (n=1,003)